To assess whether targeting YAP O‐GlcNAcylation could enhance the efficacy of current chemotherapies in obese patients, we investigated the anti‐tumor effects of gemcitabine in a high‐fat diet (HFD) BALB/c mouse model (Figure 7F–J). Here, YAP1 is linked to neoplasm.